425 related articles for article (PubMed ID: 17963806)
1. Synthesis of some epoxy and/or N-oxy 17-picolyl and 17-picolinylidene-androst-5-ene derivatives and evaluation of their biological activity.
Djurendić E; Daljev J; Sakac M; Canadi J; Santa SJ; Andrić S; Klisurić O; Kojić V; Bogdanović G; Djurendić-Brenesel M; Novaković S; Gasi KP
Steroids; 2008 Jan; 73(1):129-38. PubMed ID: 17963806
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of some 17-picolyl and 17-picolinylidene androst-5-ene derivatives.
Gasi KM; Brenesel MDj; Djurendić EA; Sakac MN; Canadi JJ; Daljev JJ; Armbruster T; Andrić S; Sladić DM; Bozić TT; Novaković IT; Juranić ZD
Steroids; 2007 Jan; 72(1):31-40. PubMed ID: 17118415
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and cytotoxic activity of some 17-picolyl and 17-picolinylidene androstane derivatives.
Djurendić EA; Ajduković JJ; Sakač MN; Csanádi JJ; Kojić VV; Bogdanović GM; Penov Gaši KM
Eur J Med Chem; 2012 Aug; 54():784-92. PubMed ID: 22770744
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of some new A,B-ring modified steroidal D-lactones.
Djurendić EA; Sakac MN; Zavis MP; Gaković AR; Canadi JJ; Andrić SA; Klisurić OR; Kojić VV; Bogdanović GM; Gasi KM
Steroids; 2008 Jul; 73(6):681-8. PubMed ID: 18384824
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biochemical studies of 17-substituted androst-3-enes and 3,4-epoxyandrostanes as aromatase inhibitors.
Cepa MM; Tavares da Silva EJ; Correia-da-Silva G; Roleira FM; Teixeira NA
Steroids; 2008 Dec; 73(14):1409-15. PubMed ID: 18691607
[TBL] [Abstract][Full Text] [Related]
6. 6beta,19-Bridged androstenedione analogs as aromatase inhibitors.
Komatsu S; Yaguchi A; Yamashita K; Nagaoka M; Numazawa M
Steroids; 2009 Nov; 74(12):884-9. PubMed ID: 19524602
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of a series of A,B-ring modified 16,17-secoandrostane derivatives.
Sakac M; Gaković A; Stojanović S; Djurendić E; Kojić V; Bogdanović G; Gasi KP
Bioorg Chem; 2008 Jun; 36(3):128-32. PubMed ID: 18304603
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationships of 6-substituted androst-4-ene analogs as aromatase inhibitors.
Numazawa M; Kamiyama T; Tachibana M; Oshibe M
J Med Chem; 1996 May; 39(11):2245-52. PubMed ID: 8667367
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antineoplastic activity of O-alkylated derivatives of 7-hydroximinoandrost-5-ene steroids.
Bansal R; Guleria S; Ries C; Hartmann RW
Arch Pharm (Weinheim); 2010 Jul; 343(7):377-83. PubMed ID: 20309873
[TBL] [Abstract][Full Text] [Related]
10. Epoxidation and reduction of cholesterol, 1,4,6-cholestatrien-3-one and 4,6-cholestadien-3beta-ol.
Ma E; Kim H; Kim E
Steroids; 2005 Apr; 70(4):245-50. PubMed ID: 15784279
[TBL] [Abstract][Full Text] [Related]
11. Effects of new C6-substituted steroidal aromatase inhibitors in hormone-sensitive breast cancer cells: Cell death mechanisms and modulation of estrogen and androgen receptors.
Augusto TV; Amaral C; Varela CL; Bernardo F; da Silva ET; Roleira FFM; Costa S; Teixeira N; Correia-da-Silva G
J Steroid Biochem Mol Biol; 2019 Dec; 195():105486. PubMed ID: 31557516
[TBL] [Abstract][Full Text] [Related]
12. Electrochemical bromination of cholest-5-enes.
Milisavljević SS; Wurst K; Laus G; Vukićević MD; Vukićević RD
Steroids; 2005 Dec; 70(13):867-72. PubMed ID: 16039678
[TBL] [Abstract][Full Text] [Related]
13. Microbial transformation of 3-hydroxy-5,6-cyclopropanocholestanes--an alternative route to 6-methylsteroids.
Yan JL; Lee SS; Wang KC
Steroids; 2000 Dec; 65(12):863-70. PubMed ID: 11077084
[TBL] [Abstract][Full Text] [Related]
14. New androst-4-en-17-spiro-1,3,2-oxathiaphospholanes. Synthesis, assignment of absolute configuration and in vitro cytotoxic and antimicrobial activities.
Krstić NM; Bjelaković MS; Pavlović VD; Robeyns K; Juranić ZD; Matić I; Novaković I; Sladić DM
Steroids; 2012 Apr; 77(5):558-65. PubMed ID: 22342468
[TBL] [Abstract][Full Text] [Related]
15. Studies of the time-dependent inactivation of aromatase by 4beta,5beta-epoxy-6-one and 5beta,6beta-epoxy-4-one steroids under various conditions.
Numazawa M; Yamada K
Biol Pharm Bull; 1999 Nov; 22(11):1207-11. PubMed ID: 10598029
[TBL] [Abstract][Full Text] [Related]
16. Improved synthesis and molecular modeling of 4beta,19-dihydroxyandrost-5-en-17-one, an excellent inhibitor of aromatase.
Numazawa M; Yamada K; Watari Y; Ando M
Chem Pharm Bull (Tokyo); 2002 May; 50(5):703-5. PubMed ID: 12036037
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of androst-4-ene-3,6,17-trione and metabolites in human urine after the administration of a food supplement by liquid chromatography/ion trap-mass spectrometry.
Deventer K; Van Eenoo P; Mikulcíková P; Van Thuyne W; Delbeke FT
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Dec; 828(1-2):21-6. PubMed ID: 16213800
[TBL] [Abstract][Full Text] [Related]
18. Steroidal metabolites transformed by Marchantia polymorpha cultures block breast cancer estrogen biosynthesis.
Hegazy ME; Gamal-Eldeen AM; El-Halawany AM; Mohamed Ael-H; Paré PW
Cell Biochem Biophys; 2012 May; 63(1):85-96. PubMed ID: 22350385
[TBL] [Abstract][Full Text] [Related]
19. Epoxidation and reduction of DHEA, 1,4,6-androstatrien-3-one and 4,6-androstadien-3beta,17beta-diol.
Ma E; Kim E
Molecules; 2005 May; 10(3):572-82. PubMed ID: 18007323
[TBL] [Abstract][Full Text] [Related]
20. The anti-aromatase effect of progesterone and of its natural metabolites 20alpha- and 5alpha-dihydroprogesterone in the MCF-7aro breast cancer cell line.
Pasqualini JR; Chetrite G
Anticancer Res; 2008; 28(4B):2129-33. PubMed ID: 18751385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
